UC Berkeley |

FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease

UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version.

UCSF |

What’s so controversial about the first gene-edited babies? Experts explain

Researcher He Jiankui’s announcement of the first babies with DNA edited as embryos causes concern.